InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,467.94
(
-0.10%
)
US TECH 100
19,204.80
(
-0.28%
)
Dow Jones
39,163.95
(
0.07%
)
Brent Oil
84.43
(
-0.68%
)
Bitcoin
63,918.43
(
-1.39%
)
Post# of 126
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Telephonics

Send PM Follow Ignore
Followers 3
Posts 1277
Boards Moderated 1
Alias Born 04/02/2003

Telephonics

Re: None

Monday, 03/27/2006 6:42:38 PM

Monday, March 27, 2006 6:42:38 PM

Post# of 126
Didn't take the company long!


Cubist Pharmaceuticals Has Submitted Response to FDA Approvable Letter Received on Friday; FDA Action Anticipated By
RedNova Mon, 27 Mar 2006 1:09 PM PST
Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) today announced that the Company has submitted to the Food & Drug Administration (FDA) an amendment to the sNDA for CUBICIN(R) (daptomycin for injection), in complete response to the FDA Approvable Letter of March 24, 2006.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news
Only $200 per official company press release!